Yulian Zhang

Synthesis and antiviral activity of HCV NS3/4A peptidomimetic boronic acid inhibitors.

P. Wei, M. Hepperle, D. A. Campbell, 2009, Bioorganic & medicinal chemistry letters.

Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88.

Alan G. E. Wilson, Vijay T. Ahuja, Y. Liu, 2015, Bioorganic & medicinal chemistry letters.

The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.

Y. Liu, A. Cacace, J. Macor, 2015, Bioorganic & medicinal chemistry letters.

Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma.

Alan G. E. Wilson, Y. Liu, D. Rice, 2009, Journal of medicinal chemistry.

Green synthesis of Cu/Fe3O4 nanoparticles using green tea extract: Evaluation of its catalytic activity, antioxidant and anti-colon cancer effects

Yue Meng, Yulian Zhang, Yao Peng, 2022, Inorganic Chemistry Communications.

Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma.

Alan G. E. Wilson, N. C. Goodwin, Y. Liu, 2015, ACS medicinal chemistry letters.

Design, synthesis, and evaluation of phenylglycinols and phenyl amines as agonists of GPR88.

Alan G. E. Wilson, Vijay T. Ahuja, Y. Liu, 2015, Bioorganic & medicinal chemistry letters.

Discovery and Development of LX7101, a Dual LIM-Kinase and ROCK Inhibitor for the Treatment of Glaucoma.

Y. Liu, Nita Patel, David B Rawlins, 2015, ACS medicinal chemistry letters.